The next remedy in the fight against what is allegedly the most terrible pandemic in living memory is about to begin: Molnupiravir from pharmaceutical giant Merck. Die New York Times, one of the most important media outlets in the United States, reported on December 13th that the drug could lead to mutations in DNA, cancer, birth defects and infertility. The risk for the unborn would be much higher than the alleged 30 percent protection for the mother.
“My answer is no, and there is no circumstance in which I would advise a pregnant woman to take this drug.”
Dr. James Hildreth, President of Meharry Medical College in Tennessee, member of the FDA Committee of Experts
Critical voices in the Expert Committee of the Food and Drug Administration FDA expressed concerns about the product. It has the potential to change the human genome. These allegations are interesting in that they are also made by critics of the Covid-19 vaccines used today. The mRNA vaccines are also suspected of being mutagenic, even if there are numerous pro and contra voices.
The drug interferes with cell division
Molnupiravir is said to be able to influence the mechanisms of cell division in the human fetus. This could lead to birth defects. This description reminds one of the Contergan catastrophe. This is due to the design of molnupiravir. The agent is supposed to change the genetic material of the coronavirus and thus prevent it from multiplying. Strictly speaking, errors should be introduced into the genome of the virus, which are so serious that it can no longer exist. Whether this concept is so clever is questionable, because if you look closely, defects in the genetic material are nothing more than mutations – and it is anything but certain that every virus loses its ability to divide cells as a result of such mutations. What if just as particularly dangerous new variants emerge, or actually have to emerge?
Miscarriages, changes in sperm
Some scientists suggest that the same mechanism of action could cause defects in human cells. This could lead to cancer, cause birth defects mentioned above or change sperm, among other things. This suspicion was confirmed in animal experiments – hamster tissues changed accordingly after giving molnupiravir. Children and adolescents would be particularly at risk, as the drug interferes with cell division, which occurs much more frequently at a young age. But the scientists quoted in the New York Times also see the danger in adults as a given, especially with regard to the constantly dividing male sperm.
Merck assures security
The pharmaceutical giant Merck replied that the experiment with the animal tissue took much longer than the aim of treating humans. In animal experiments, the effect was examined over 32 days, but people should only take the drug for five days. Merck’s chief medical officer asserted that the drug’s mutagenic properties were “very low”. To be on the safe side, pregnant women and nursing mothers were excluded from the test series.
In animal experiments with rats, stillbirths and abortions
Another indication that the drug could be extremely dangerous comes from research by Merck itself. In animal experiments, pregnant rats would have suffered more miscarriages or gave birth to miscarriages. Scientists are now urging Merck to fully disclose the results of the animal experiments in question.